Genetic mutation during embryonic development could hold the key to a lifetime living with diabetes

Genetic mutation during embryonic development could hold the key to a lifetime living with diabetes
A*STAR researchers show that HNF1B mutation affects the development of the pancreas in MODY5 patients which means they develop diabetes by early adulthood. The image above depicts a human islet containing alpha and beta cells. Credit: A*STAR Institute of Molecular and Cell Biology

Personalized treatment for people with diabetes could be a step closer after researchers discovered how a single gene mutation fundamentally alters pancreatic development.

The A*STAR researchers discovered that a point mutation in a gene known as HNF1B halts the embryonic of the pancreas; it stops the growth of the vital beta cells, which produce the insulin that maintains a body's sugar balance.

Improved understanding of beta cell development could lead to better-targeted diabetes treatments, explains study leader Adrian Teo, from the A*STAR Institute of Molecular and Cell Biology (IMCB).

"By understanding the role of these beta cell genes, we can understand the mechanistic cause of diabetes," Teo says. "This may mean that eventually we could stratify our diabetic population into subgroups and treat them appropriately based on disease mechanism rather than just blood glucose levels".

The team used pluripotent stem cell lines from people with a rare form of inherited diabetes called maturity onset diabetes of the young, type 5 (MODY5), comparing them to cells grown from unaffected family members and healthy controls.

In MODY5, children who inherit the from one parent grow a malformed and small pancreas, which means they develop diabetes usually before the age of 25.

"We used MODY5 patient-specific induced to go back in time, mimicking human pancreas development in our cell culture dish," Teo explains. "Amazingly, we discovered that HNF1B gene mutation actually affected the development of the human pancreas very early in life."

While there are a number of subtypes of MODY associated with a range of gene mutations, the team found HNF1B worked independently of all of those. In the early days of development the differentiating actually up-regulated other pancreatic development genes, in what may have been an attempt to compensate for the HNF1B mutation.

"We saw the same effects in numerous affected cell lines that were clearly distinct from the healthy family member and non related healthy control," Teo says.

"Together, these comparisons allowed us to study human diabetes mechanisms in an actual genetic background which is different to other models that typically do not account for true human genetic background."

The team are now using a similar pluripotent stem cell method to examine the pancreatic defects involved in other forms of .

"Diabetes is a complex disease arising from a combination of genes and environment, but this model can help us understand the contribution that individual genes make to beta cell function," Teo explains.

Explore further

Discovery of insulin-producing beta cell subtypes may impact diabetes treatment

More information: Adrian Kee Keong Teo et al. Early Developmental Perturbations in a Human Stem Cell Model of MODY5/HNF1B Pancreatic Hypoplasia, Stem Cell Reports (2016). DOI: 10.1016/j.stemcr.2016.01.007
Journal information: Stem Cell Reports

Citation: Genetic mutation during embryonic development could hold the key to a lifetime living with diabetes (2016, August 24) retrieved 19 August 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more